Feb 02, 2016 21:30 pm UTC| Business
SOUTHFIELD, Mich., Feb. 02, 2016 -- Federal-Mogul Holdings Corporation (NASDAQ:FDML) today announced that the company’s fourth quarter and full-year 2015 financial results conference call and audio webcast will be held...
Kaiser Aluminum Announces Fourth Quarter and Full Year 2015 Earnings Release and Conference Call
Feb 02, 2016 21:30 pm UTC| Business
FOOTHILL RANCH, Calif., Feb. 02, 2016 -- Kaiser Aluminum Corporation (NASDAQ:KALU) today announced that it plans to release its fourth quarter and full year 2015 financial and operating results on Tuesday, February 16,...
Wabash National Corporation Announces Record Fourth Quarter and Full Year 2015 Results
Feb 02, 2016 21:25 pm UTC| Business
Fourth quarter and full year GAAP earnings of $0.50 and $1.50 per diluted share, up 85.2 percent and 76.5 percent, respectively, over prior year periodFourth quarter and full year non-GAAP adjusted earnings of $0.51 and...
Builders FirstSource Provides Preliminary Results for the Fourth Quarter Ended December 31, 2015
Feb 02, 2016 21:23 pm UTC| Business
DALLAS, Feb. 02, 2016 -- Builders FirstSource, Inc. (the “Company”) (Nasdaq:BLDR), a leading supplier and manufacturer of structural and related building products for residential new construction and home repair and...
Ocera to Present at the 18th Annual BIO CEO & Investor Conference
Feb 02, 2016 21:20 pm UTC| Business
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2016 -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced...
Wabash National Corporation Announces $100 Million Stock Repurchase Program
Feb 02, 2016 21:20 pm UTC| Business
LAFAYETTE, Ind., Feb. 02, 2016 -- Wabash National Corporation (“Wabash” or “the Company”) (NYSE:WNC) today announced that its board of directors has authorized the Company to repurchase up to $100 million of its common...
SteadyMed to Present at 18th Annual BIO CEO & Investor Conference
Feb 02, 2016 21:15 pm UTC| Business
SAN RAMON, Calif., Feb. 02, 2016 -- SteadyMed Ltd. (Nasdaq:STDY), a pre-NDA stage specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases with unmet...